Rautiainen J, Auriola S, Rouvinen J, Kauppinen J, Zeiler T, Novikov D, Virtanen T, Mäntyjärvi R A
Department of Clinical Microbiology, University of Kuopio, Finland.
Biochem Biophys Res Commun. 1998 Jun 29;247(3):746-50. doi: 10.1006/bbrc.1998.8851.
The relationship between the molecular structure of allergenic proteins and the allergenic determinants is one of the central issues in allergology. We report here that the natural preparation of Bos d 2, a mammalian lipocalin allergen, comprises three molecular variant proteins of 17,829, 17,781, and 17,800 Da. When cDNA of Bos d 2 (Genome Sequence Data Base No. L42867) was recloned and expressed in Pichia pastoris, two proteins were produced. One of the proteins (17,831 Da) and the proteins in the natural preparation had pyroglutamate as the N-terminal residue; in the other (17,849 Da) the N-terminal residue was glutamine. Recombinant Bos d 2 protein was crystallized and the native data set was collected at 1.8 A resolution.
变应原蛋白的分子结构与变应原决定簇之间的关系是过敏反应学的核心问题之一。我们在此报告,哺乳动物脂质运载蛋白变应原Bos d 2的天然制剂包含三种分子量分别为17,829、17,781和17,800 Da的分子变异蛋白。当Bos d 2的cDNA(基因组序列数据库编号L42867)被重新克隆并在毕赤酵母中表达时,产生了两种蛋白。其中一种蛋白(17,831 Da)和天然制剂中的蛋白以焦谷氨酸作为N端残基;另一种(17,849 Da)的N端残基是谷氨酰胺。重组Bos d 2蛋白被结晶,并在1.8埃分辨率下收集了天然数据集。